Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-013 Berry Genomics Co.Ltd(000710)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shareholders’ meeting did not veto the proposal.
2. This general meeting of shareholders does not involve changing the resolutions adopted by previous general meetings of shareholders.
1、 Meetings held
1. Meeting time:
(1) On site meeting time: 15:30 PM, Monday, February 7, 2022
(2) Online voting time:
Among them, the specific time of online voting through the trading system of Shenzhen stock exchange is: 9:15-9:25, 9:30-11:30 and 13:00-15:00 on February 7, 2022;
The specific time of voting through the Internet voting system of Shenzhen stock exchange is 9:15-15:00 on February 7, 2022.
2. Venue: conference room on the 6th floor of the company, building 5, courtyard 4, shengshengyuan Road, Changping District, Beijing
3. Meeting mode:
This general meeting of shareholders adopts the combination of on-site voting and online voting. The company adopts the trading system and Internet voting system of Shenzhen Stock Exchange（ http://wltp.cn.info.com.cn. ）Provide all shareholders with a voting platform in the form of network, and shareholders can exercise their voting rights through the above system during online voting time. The general meeting of shareholders of the company selects one of on-site voting and online voting. If there is repeated voting for the same voting right, the first voting result shall prevail.
4. Convener: Board of directors
The proposal of the 15th meeting of the board of directors was considered and adopted.
5. Moderator: Mr. Gao Yang, chairman of the company
This general meeting of shareholders complies with relevant laws, administrative regulations, departmental rules, normative documents, the business rules of the exchange and the articles of association.
2、 Attendance at the meeting
Three shareholders (including one authorized representative) attended the on-site meeting, representing 998409 shares, accounting for 0.2816% of the total shares of the company.
14 shareholders attended the meeting through online voting, representing 114020422 shares, accounting for 32.1541% of the total shares of the company.
A total of 17 shareholders attended the meeting, representing 115018831 shares, accounting for 32.4357% of the total shares of the company. Among them, 14 minority shareholders attended the meeting, representing 7350598 shares, accounting for 2.0729% of the total shares of the company.
Some directors, supervisors, senior managers and lawyers hired by the company attended the shareholders’ meeting. 3、 Deliberation and voting of proposals
1. The proposal of this shareholders’ meeting adopts on-site voting and online voting.
2. The proposal of the shareholders’ meeting “1.00 proposal on the company’s waiver of the right to implement equity acquisition of Fujian and Rui acquiree in the first window period” was adopted. The specific voting conditions are as follows:
Total voting result:
114896531 shares were approved, accounting for 99.8937% of the shares held by all shareholders attending the meeting; Against 122300 shares, accounting for 0.1063% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Voting results of minority shareholders:
7228298 shares were approved, accounting for 98.3362% of the shares held by minority shareholders attending the meeting; Against 122300 shares, accounting for 1.6638% of the shares held by minority shareholders attending the meeting; Abstain from 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by minority shareholders attending the meeting.
3. The related shareholders of this general meeting are as follows:
Whether the number of shares held by the shareholder’s name and related relationship has been avoided voting
Hongling Siqi (Zhuhai) and the executive partner of the shareholder
Wang Hongxia (Wang Hongxia), female, an equity investment enterprise (with a statement), is 30000000
Limited partnership) also served as the director of the company and proposed at this meeting
Directors of the subject company of the transaction involved in the case
Tianjin junruiqi equity invests in Wang, the director and general manager of the controlling shareholder of the shareholder
Mr. He Junfeng is also a director of the company
(partner)
Zhou Daixing (the shareholder also serves as the director of the company and the 447200 shareholders of this meeting)
(acting star) the directors of the subject company of the transaction involved in the proposal
The above “number of shares held” refers to the number of shares held by the closing date of the equity registration date of the shareholders’ meeting (January 24, 2022).
4、 Legal opinions issued by lawyers
Name of law firm: Kindu law firm
Name of Lawyer: Xie Yuanxun, Liu Yang
Concluding observations: the convening and convening procedures of the general meeting of shareholders of the company comply with the provisions of the company law, the securities law and other relevant laws and administrative regulations, the rules of the general meeting of shareholders and the articles of Association; The qualifications of the persons attending the shareholders’ meeting and the convener are legal and valid; The voting procedures and results of this general meeting of shareholders are legal and valid.
5、 Documents for future reference
1. The resolution of the shareholders’ meeting signed and confirmed by the attending directors and recorder and stamped with the seal of the board of directors
2. Legal opinion
Berry Genomics Co.Ltd(000710) board of directors February 7, 2022
